Senior insider sale
Chief Financial Officer at PUMA BIOTECHNOLOGY, INC. — senior position signals high conviction
$33.7K
9.45K shares
What this filing means
NOUGUES MAXIMO F plans to sell 9.45K shares of PUMA BIOTECHNOLOGY, INC. valued at approximately $33.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/17/2024ACC: 0001610717-24-000402
Officer· Chief Financial Officer
Since Nov 2018
9.45K
Shares to sell
$33.7K
Approx. market value
43.31K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Grant
Compensation for Services Rendered
2/12/2024
43.31KTotal acquired43.31K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/12/2024 | Restricted Stock Unit Grant Compensation for Services Rendered | 43.31K | — |
| Total | 43.31K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
5.29K
Market value
$17.3K
7/2/2024
Planned — Approximate Date
NASDAQGSPlanned
Units to sell
4.16K
Market value
$16.4K
7/17/2024
Total
Units
9.45K
Value
$33.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/2/2024 | 5.29K | $17.3K | — | Completed |
| Planned — Approximate Date | ||||
7/17/2024 | 4.16K | $16.4K | NASDAQGS | Planned |
| Total | 9.45K | $33.7K | ||